FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to oncology. Catheterisation of patient's venous system is carried out. Fibre-optic spectrometer sensor is moved via veins to corresponding organs to the level of segmental veins and absorption coefficient of sample β is determined in real time mode. β value higher or equal 900 cm-1 testifies to presence of malignant neoplasm or metastases in organ or its segment.
EFFECT: method makes it possible to determine metastatic disease at early stages, point to exact metastasis localisation.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD, REVEALING GROUPS OF RISK OF DEVELOPMENT OF RELAPSE AND METASTASISES OF MAMMARY GLAND CANCER | 2007 |
|
RU2352256C2 |
METHOD FOR COLORECTAL CANCER METASTASES DIAGNOSTICS IN LIVER | 2016 |
|
RU2642247C1 |
METHOD FOR TREATMENT OF MALIGNANT NEUROENDOCRINAL TUMOURS OF PANCREAS HEAD WITH METASTASES IN LIVER | 2016 |
|
RU2625275C1 |
METHOD OF PREDICTING DISSEMINATION OF TUMOUR PROCESS IN PATIENTS WITH STOMACH CANCER | 2011 |
|
RU2455924C1 |
METHOD FOR TREATMENT OF RESECTABLE PRIMARY LOCALLY ADVANCED MALIGNANT NEUROENDOCRINAL TUMOURS OF PANCREAS HEAD | 2016 |
|
RU2625271C1 |
METHOD OF RECTAL CANCER TREATMENT | 2007 |
|
RU2336038C1 |
METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
METHOD FOR PREDICTING THE COURSE OF THE DISEASE IN PATIENTS WITH LOCAL RENAL CELL CARCINOMA OF THE KIDNEY | 2018 |
|
RU2674677C1 |
METHOD FOR TREATMENT OF PRIMARY LOCALIZED MALIGNANT NEUROENDOCRINAL TUMOURS OF PANCREAS HEAD | 2016 |
|
RU2625276C1 |
METHOD FOR PREDICTION OF RECURRENCES OF POSTOPERATIVE MENINGIOMAS | 2018 |
|
RU2689795C1 |
Authors
Dates
2013-12-27—Published
2012-01-24—Filed